Patent · US Active

Multidomain peptides for promoting angiogenesis

US9526762B1 · kind B1 · utility

4Cited by
9References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 8, 2014
Grant dateDec 27, 2016
Priority date
Expiry dateAug 8, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/412
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides a composition comprising a multi-domain peptide capable of self-assembly into a nanofibrous hydrogel structure capable of stimulating a robust angiogenic response. In one embodiment, the composition comprises a short 15 amino acid VEGF-165 peptide mimic conjugated to a 16 amino acid multidomain peptide. A method for promoting angiogenesis and/or treating ischemic wounds in a subject is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.